Castrate Resistant Prostate Cancer Enhertu Therapy

NCT06610825 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

Washington D.C. Veterans Affairs Medical Center

Collaborators